Abstract
Piroxicam beta-cyclodextrin has recently been observed to be equal to, or even possibly to be superior to, indomethacin (mainly with regard to side effects) in a single case of hemicrania continua. Piroxicam beta- cyclodextrin, 20 to 40 mg per day, was, accordingly, tried in six patients with chronic paroxysmal hemicrania and six patients with hemicrania continua with a previously proven response to indomethacin. The study was conducted over a period of 3 weeks and in an open fashion. A placebo effect is considered to be negligible in these disorders. In such a comparison, piroxicam beta-cyclodextrin seemed inferior to indomethacin, in particular in chronic paroxysmal hemicrania.
| Original language | English |
|---|---|
| Pages (from-to) | 549-550 |
| Number of pages | 2 |
| Journal | Headache |
| Volume | 35 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 1995 |
Fingerprint
Keywords
- chronic paroxysmal hemicrania
- hemicrania continua
- piroxicam
ASJC Scopus subject areas
- Clinical Neurology
- Neuroscience(all)
Cite this
A piroxicam derivative partly effective in chronic paroxysmal hemicrania and hemicrania continua. / Sjaastad, O.; Antonaci, F.
In: Headache, Vol. 35, No. 9, 1995, p. 549-550.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - A piroxicam derivative partly effective in chronic paroxysmal hemicrania and hemicrania continua
AU - Sjaastad, O.
AU - Antonaci, F.
PY - 1995
Y1 - 1995
N2 - Piroxicam beta-cyclodextrin has recently been observed to be equal to, or even possibly to be superior to, indomethacin (mainly with regard to side effects) in a single case of hemicrania continua. Piroxicam beta- cyclodextrin, 20 to 40 mg per day, was, accordingly, tried in six patients with chronic paroxysmal hemicrania and six patients with hemicrania continua with a previously proven response to indomethacin. The study was conducted over a period of 3 weeks and in an open fashion. A placebo effect is considered to be negligible in these disorders. In such a comparison, piroxicam beta-cyclodextrin seemed inferior to indomethacin, in particular in chronic paroxysmal hemicrania.
AB - Piroxicam beta-cyclodextrin has recently been observed to be equal to, or even possibly to be superior to, indomethacin (mainly with regard to side effects) in a single case of hemicrania continua. Piroxicam beta- cyclodextrin, 20 to 40 mg per day, was, accordingly, tried in six patients with chronic paroxysmal hemicrania and six patients with hemicrania continua with a previously proven response to indomethacin. The study was conducted over a period of 3 weeks and in an open fashion. A placebo effect is considered to be negligible in these disorders. In such a comparison, piroxicam beta-cyclodextrin seemed inferior to indomethacin, in particular in chronic paroxysmal hemicrania.
KW - chronic paroxysmal hemicrania
KW - hemicrania continua
KW - piroxicam
UR - http://www.scopus.com/inward/record.url?scp=0028839854&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028839854&partnerID=8YFLogxK
U2 - 10.1111/j.1526-4610.1995.hed3509549.x
DO - 10.1111/j.1526-4610.1995.hed3509549.x
M3 - Article
C2 - 8530280
AN - SCOPUS:0028839854
VL - 35
SP - 549
EP - 550
JO - Headache
JF - Headache
SN - 0017-8748
IS - 9
ER -